Cargando…
La sécurité virale des médicaments d’origine biologique()()
The viral safety of biologicals, either human blood derivatives or animal products or recombinant proteins issued from biotechnology, relies on the quality of the starting material, the manufacturing process and, if necessary, the control of the final product. The quality of the starting material is...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094260/ https://www.ncbi.nlm.nih.gov/pubmed/18706341 http://dx.doi.org/10.1016/j.pharma.2008.05.004 |